Total Payments
$6,525
2024 Payments
$103.76
Companies
31
Transactions
135
Medicare Patients
3,413
Medicare Billing
$407,264
Payment Breakdown by Category
Food & Beverage$4,052 (62.1%)
Other$1,500 (23.0%)
Travel$935.07 (14.3%)
Education$37.65 (0.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,052 | 126 | 62.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1,500 | 1 | 23.0% |
| Travel and Lodging | $935.07 | 3 | 14.3% |
| Education | $37.65 | 1 | 0.6% |
| Unspecified | $0 | 4 | 0.0% |
Payments by Type
General
$6,525
131 transactions
Ownership
$0
4 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan Inc. | $2,915 | 8 | $0 (2019) |
| ABBVIE INC. | $1,233 | 47 | $0 (2024) |
| Covidien LP | $553.67 | 6 | $0 (2018) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $304.03 | 13 | $0 (2024) |
| Janssen Scientific Affairs, LLC | $194.16 | 1 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $167.59 | 9 | $0 (2023) |
| Gilead Sciences, Inc. | $155.93 | 3 | $0 (2018) |
| Janssen Biotech, Inc. | $116.34 | 8 | $0 (2023) |
| Endogastric Solutions, Inc | $107.84 | 1 | $0 (2021) |
| Takeda Pharmaceuticals America, Inc. | $104.55 | 4 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $103.76 | 6 | ABBVIE INC. ($30.76) |
| 2023 | $919.67 | 30 | AbbVie Inc. ($317.93) |
| 2022 | $390.74 | 15 | ABBVIE INC. ($362.16) |
| 2021 | $234.61 | 6 | Endogastric Solutions, Inc ($107.84) |
| 2020 | $33.61 | 2 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($19.26) |
| 2019 | $299.05 | 18 | AbbVie, Inc. ($80.53) |
| 2018 | $1,029 | 31 | Covidien LP ($375.45) |
| 2017 | $3,515 | 27 | Allergan Inc. ($2,874) |
All Payment Transactions
135 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $27.07 | General |
| Category: LIVER DISEASE | ||||||
| 11/18/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $16.77 | General |
| Category: IMMUNOLOGY | ||||||
| 10/16/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $13.99 | General |
| Category: IMMUNOLOGY | ||||||
| 04/10/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $16.05 | General |
| Category: Gastroenterology | ||||||
| 01/17/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $29.88 | General |
| Category: Neuroscience | ||||||
| 2024 | GastroGPO, LLC | — | — | — | $0.00 | Ownership |
| 11/30/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | CYLTEZO (Drug) | Food and Beverage | In-kind items and services | $23.54 | General |
| Category: CNS | ||||||
| 11/30/2023 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $6.21 | General |
| Category: Immunology | ||||||
| 11/16/2023 | VIVUS LLC | PANCREAZE (Drug) | Food and Beverage | In-kind items and services | $17.68 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/07/2023 | AbbVie Inc. | VIBERZI (Drug), LINZESS | Food and Beverage | In-kind items and services | $22.10 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/24/2023 | AbbVie Inc. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $16.16 | General |
| Category: IMMUNOLOGY | ||||||
| 10/18/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), PLENVU | Food and Beverage | In-kind items and services | $26.70 | General |
| Category: Gastroenterology | ||||||
| 10/11/2023 | Janssen Scientific Affairs, LLC | STELARA (Biological) | Food and Beverage | In-kind items and services | $194.16 | General |
| Category: Immunology | ||||||
| 09/13/2023 | AbbVie Inc. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $6.81 | General |
| Category: IMMUNOLOGY | ||||||
| 09/07/2023 | Braintree Laboratories, Inc. | SUFLAVE (Drug) | Food and Beverage | In-kind items and services | $17.21 | General |
| Category: GI COLON PREP | ||||||
| 09/05/2023 | AbbVie Inc. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $6.00 | General |
| Category: IMMUNOLOGY | ||||||
| 08/30/2023 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $89.04 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 08/17/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $23.52 | General |
| Category: Neuroscience | ||||||
| 07/18/2023 | AbbVie Inc. | VIBERZI (Drug), LINZESS | Food and Beverage | In-kind items and services | $8.14 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/27/2023 | Organon LLC | HADLIMA (Drug), RENFLEXIS | Food and Beverage | In-kind items and services | $25.53 | General |
| Category: ADALIMUMAB-BWWD | ||||||
| 05/18/2023 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $27.24 | General |
| Category: INTERNAL MEDICINE | ||||||
| 04/26/2023 | AbbVie Inc. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $9.40 | General |
| Category: IMMUNOLOGY | ||||||
| 04/03/2023 | AbbVie Inc. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $8.64 | General |
| Category: IMMUNOLOGY | ||||||
| 03/23/2023 | Takeda Pharmaceuticals U.S.A., Inc. | GATTEX (Drug) | Food and Beverage | In-kind items and services | $24.55 | General |
| Category: INTERNAL MEDICINE | ||||||
| 03/23/2023 | AbbVie Inc. | VIBERZI (Drug), LINZESS | Food and Beverage | In-kind items and services | $5.69 | General |
| Category: GASTROENTEROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 812 | 908 | $540,603 | $94,637 |
| 2022 | 17 | 835 | 997 | $541,605 | $99,186 |
| 2021 | 16 | 960 | 1,118 | $636,855 | $117,786 |
| 2020 | 16 | 806 | 937 | $479,271 | $95,656 |
Total Patients
3,413
Total Services
3,960
Medicare Billing
$407,264
Procedure Codes
66
All Medicare Procedures & Services
66 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 62 | 62 | $88,350 | $13,399 | 15.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 126 | 206 | $41,200 | $13,322 | 32.3% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 113 | 117 | $35,100 | $12,150 | 34.6% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 113 | 115 | $106,250 | $9,824 | 9.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 63 | 73 | $15,476 | $6,599 | 42.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 48 | 48 | $19,536 | $6,416 | 32.8% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 59 | 59 | $73,443 | $5,498 | 7.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 50 | 50 | $16,400 | $5,482 | 33.4% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 27 | 27 | $38,718 | $5,196 | 13.4% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 30 | 30 | $35,700 | $4,423 | 12.4% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 20 | 20 | $28,680 | $3,737 | 13.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 37 | 37 | $5,550 | $2,650 | 47.7% |
| 43246 | Insertion of stomach tube using a flexible endoscope | Facility | 2023 | 11 | 11 | $12,650 | $1,897 | 15.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 21 | 21 | $5,250 | $1,890 | 36.0% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 18 | 18 | $16,200 | $1,608 | 9.9% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 14 | 14 | $2,100 | $547.69 | 26.1% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 181 | 310 | $62,000 | $18,064 | 29.1% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 64 | 64 | $91,200 | $13,699 | 15.0% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 74 | 83 | $24,900 | $9,307 | 37.4% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 108 | 111 | $99,900 | $8,921 | 8.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 76 | 88 | $18,656 | $8,401 | 45.0% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 39 | 40 | $16,280 | $6,559 | 40.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 53 | 53 | $17,384 | $6,398 | 36.8% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 65 | 71 | $17,750 | $6,068 | 34.2% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 50 | 51 | $63,189 | $5,319 | 8.4% |
About Dr. Brian Blumenstein, MD
Dr. Brian Blumenstein, MD is a Gastroenterology healthcare provider based in Oak Lawn, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/22/2006. The National Provider Identifier (NPI) number assigned to this provider is 1194784645.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Brian Blumenstein, MD has received a total of $6,525 in payments from pharmaceutical and medical device companies, with $103.76 received in 2024. These payments were reported across 135 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($4,052).
As a Medicare-enrolled provider, Blumenstein has provided services to 3,413 Medicare beneficiaries, totaling 3,960 services with total Medicare billing of $407,264. Data is available for 4 years (2020–2023), covering 66 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Oak Lawn, IL
- Active Since 03/22/2006
- Last Updated 01/15/2009
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1194784645
Products in Payments
- LINZESS (Drug) $2,913
- RINVOQ (Biological) $323.32
- STELARA (Biological) $310.50
- SKYRIZI (Biological) $304.83
- Barrx (Device) $241.54
- XIFAXAN (Drug) $181.35
- Manometry (Device) $164.46
- Epclusa (Drug) $121.94
- Entyvio (Biological) $114.94
- ESOPHYX (Device) $107.84
- XELJANZ (Drug) $103.71
- Humira (Biological) $100.30
- TRULANCE (Drug) $97.28
- Cimzia (Drug) $87.02
- Creon (Drug) $77.97
- GATTEX (Drug) $75.64
- HUMIRA (Biological) $69.84
- VIBERZI (Drug) $58.39
- ENTYVIO (Biological) $56.27
- ZEPOSIA (Drug) $53.40
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Oak Lawn
Dr. Rogelio Silva, M.d, M.D
Gastroenterology — Payments: $446,253
Gastroenterology $446,253
Kamran Ayub, Md, MD
Gastroenterology — Payments: $289,123
Gastroenterology $289,123
Thomas Arndt, Md, MD
Gastroenterology — Payments: $15,103
Gastroenterology $15,103
Imad Elkhatib, M.d, M.D
Gastroenterology — Payments: $5,371
Gastroenterology $5,371
Samir Patel, Md, MD
Gastroenterology — Payments: $4,166
Gastroenterology $4,166
Dr. Hareth Raddawi, Md, MD
Gastroenterology — Payments: $3,959
Gastroenterology $3,959